Everolimus Plus CsA Improves Renal Function in Kidney Transplant Recipients - Medscape PDF Print
MedscapeBoth everolimus groups were statistically noninferior to the MPA control group for the composite efficacy end point and for renal function at 12 months.

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.